B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

JUN

MOLECULAR TARGET

Jun proto-oncogene, AP-1 transcription factor subunit

UniProt: P05412NCBI Gene: 372575 compounds

JUN (Jun proto-oncogene, AP-1 transcription factor subunit) is targeted by 75 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting JUN

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Colchicine1.614
2DEAD-box RNA Helicases1.393
3Thioctic Acid1.393
4Diphenhydramine1.393
5Disulfiram1.393
6glaucarubinone1.393
7Thioctic Acid1.393
8vinblastine sulfate1.393
9egcg1.102
10Methylene Blue1.102
11Amoxapine1.102
12Cinnarizine1.102
13Clofibrate1.102
14Ethoxyquin Antioxidant; also1.102
15Fenofibrate1.102
16Lithocholic Acid1.102
17Lovastatin1.102
18Lynestrenol1.102
19Medroxyprogesterone Acetate1.102
20Vitamin K 31.102
21Mestranol1.102
22Phenoxybenzamine1.102
23Podophyllotoxin1.102
24Promethazine1.102
25triflupromazine hydrochloride1.102
26Vincamine1.102
27Azithromycin0.691
28Budesonide0.691
29Fluoxetine0.691
30Iodine0.691
31Mianserin0.691
32Sertraline0.691
33Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).0.691
34Taurine0.691
35vinpocetine0.691
36Bupranolol0.691
37Chlormadinone Acetate0.691
38Clotrimazole0.691
39Cyproheptadine0.691
40Desoxycorticosterone0.691
41Dihydrotestosterone0.691
42Dimenhydrinate0.691
43Dimethisterone0.691
44Domperidone0.691
45eliprodil0.691
46ethopropazine hydrochloride0.691
47Ethynodiol Diacetate0.691
48Fluvoxamine0.691
49Gemfibrozil0.691
50iodoform0.691

Showing top 50 of 75 compounds. Use the BiohacksAI search to explore all JUN modulators.

About JUN as a Drug Target

JUN (Jun proto-oncogene, AP-1 transcription factor subunit) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 75 compounds with documented JUN interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

JUN inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.